Literature DB >> 29967941

Combined Used of Rheology and LF-NMR for the Characterization of PVP-Alginates Gels Containing Liposomes.

Giulia Fanesi1, Michela Abrami2, Francesca Zecchin2, Irina Giassi2, Elena Dal Ferro1, Anja Boisen1, Gabriele Grassi3, Paolo Bertoncin4, Mario Grassi5, Paolo Marizza1.   

Abstract

PURPOSE: This paper is based on the characterization of the rheological and Low Field NMR (LF-NMR) properties of an interpenetrated hydrogel made up by poly(N-vinyl-2-pyrrolidone) and sodium alginate. The final aim is to use the hydrogel as a delivery matrix for liposomes, widely used tools in the drug delivery field.
METHODS: Rheology, LF-NMR, TEM, cryo-TEM, confocal laser scanning microscopy and release test were employed to characterize the interpenetrated hydrogel. Different theoretical approaches such as Flory, Chui, Scherer and Schurz theories were used to interpret the experimental results.
RESULTS: We found that the crosslinking mechanisms of the two polymers produced an anti-synergistic effect on the final mechanical properties of the interpenetrated hydrogel. Instead of creating a continuous network, alginate formed isolated, cross-linked, clusters embedded in a continuous network of poly(N-vinyl-2-pyrrolidone). Additionally, gel structure significantly influenced liposome delivery.
CONCLUSIONS: The rheological and LF-NMR characterization were confirmed and supported by the independent techniques TEM, cryo-TEM and release tests Thus, our findings reiterate the potentiality of both rheology and LF-NMR for the characterisation of soft materials such as interpenetrated polymeric networks.

Entities:  

Keywords:  Gel; LF-NMR; TEM; liposomes delivery; rheology

Mesh:

Substances:

Year:  2018        PMID: 29967941     DOI: 10.1007/s11095-018-2427-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

Review 1.  Therapeutic potential of hammerhead ribozymes in the treatment of hyper-proliferative diseases.

Authors:  G Grassi; P Dawson; G Guarnieri; R Kandolf; M Grassi
Journal:  Curr Pharm Biotechnol       Date:  2004-08       Impact factor: 2.837

2.  Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.

Authors:  Rossella Farra; Barbara Dapas; Gabriele Pozzato; Bruna Scaggiante; Francesco Agostini; Cristina Zennaro; Mario Grassi; Natalia Rosso; Carlo Giansante; Nicola Fiotti; Gabriele Grassi
Journal:  Dig Liver Dis       Date:  2011-08-09       Impact factor: 4.088

3.  Hammerhead ribozymes targeted against cyclin E and E2F1 cooperate to down-regulate coronary smooth muscle cell proliferation.

Authors:  G Grassi; A Schneider; S Engel; G Racchi; R Kandolf; A Kuhn
Journal:  J Gene Med       Date:  2005-09       Impact factor: 4.565

Review 4.  Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.

Authors:  Lucia Scarabel; Francesca Perrone; Marica Garziera; Rossella Farra; Mario Grassi; Francesco Musiani; Concetta Russo Spena; Barbara Salis; Lucia De Stefano; Giuseppe Toffoli; Flavio Rizzolio; Federica Tonon; Michela Abrami; Gianluca Chiarappa; Gabriele Pozzato; Giancarlo Forte; Gabriele Grassi; Barbara Dapas
Journal:  Expert Opin Drug Deliv       Date:  2017-02-17       Impact factor: 6.648

5.  In vivo and in vitro release of lysozyme from cross-linked gelatin hydrogels: a model system for the delivery of antibacterial proteins from prosthetic heart valves.

Authors:  A J Kuijpers; P B van Wachem; M J van Luyn; G H Engbers; J Krijgsveld; S A Zaat; J Dankert; J Feijen
Journal:  J Control Release       Date:  2000-07-03       Impact factor: 9.776

Review 6.  Ribozymes: structure, function, and potential therapy for dominant genetic disorders.

Authors:  G Grassi; J C Marini
Journal:  Ann Med       Date:  1996-12       Impact factor: 4.709

Review 7.  Liposomes as siRNA delivery vectors.

Authors:  Sabrina Bochicchio; Annalisa Dalmoro; Anna Angela Barba; Gabriele Grassi; Gaetano Lamberti
Journal:  Curr Drug Metab       Date:  2014       Impact factor: 3.731

Review 8.  Therapeutic potential of nucleic acid-based drugs in coronary hyper- proliferative vascular diseases.

Authors:  G Grassi; B Scaggiante; B Dapas; R Farra; F Tonon; G Lamberti; A Barba; S Fiorentino; N Fiotti; F Zanconati; M Abrami; M Grassi
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

9.  Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs.

Authors:  Rossella Farra; Bruna Scaggiante; Chiara Guerra; Gabriele Pozzato; Mario Grassi; Fabrizio Zanconati; Francesca Perrone; Cinzia Ferrari; Francesco Trotta; Gabriele Grassi; Barbara Dapas
Journal:  Int J Pharm       Date:  2017-02-14       Impact factor: 5.875

Review 10.  Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs.

Authors:  Anna Angela Barba; Gaetano Lamberti; Carla Sardo; Barbara Dapas; Michela Abrami; Mario Grassi; Rossella Farra; Federica Tonon; Giancarlo Forte; Francesco Musiani; Mariano Licciardi; Gabriele Pozzato; Fabrizio Zanconati; Bruna Scaggiante; Gabriele Grassi; Gennara Cavallaro
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

View more
  2 in total

Review 1.  Smart Hydrogels in Tissue Engineering and Regenerative Medicine.

Authors:  Somasundar Mantha; Sangeeth Pillai; Parisa Khayambashi; Akshaya Upadhyay; Yuli Zhang; Owen Tao; Hieu M Pham; Simon D Tran
Journal:  Materials (Basel)       Date:  2019-10-12       Impact factor: 3.623

Review 2.  Significance of Crosslinking Approaches in the Development of Next Generation Hydrogels for Corneal Tissue Engineering.

Authors:  Promita Bhattacharjee; Mark Ahearne
Journal:  Pharmaceutics       Date:  2021-02-28       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.